Uncategorized
iStent inject maintains IOP reduction at 18 months
NEW ORLEANS — A second-generation trabecular micro-bypass stent significantly reduced IOP with no intraoperative complications, according to a study presented here.At the American Society of Cataract and Refractive Surgery meeting, Richard L. Lindstrom, MD, reported 18-month results obtained with the iStent inject trabecular micro-bypass stent (Glaukos) implanted in patients with mild to moderate glaucoma that was well controlled on a single medication.